{
  "id": 2446644,
  "title": "Myomo chief medical officer sells $29,895 in shares",
  "url": "https://urgent.news/2026/08/21/myomo-chief-medical-officer-sells-29-895-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-21T22:31:55.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/myomo-chief-medical-officer-sells-29895-in-shares-93CH-4872204"
  },
  "original_language": "en",
  "account": "MYOMO, INC. (NASDAQ:MYO)'s Chief Medical Officer, Harry Kovelman, divested 17,250 shares of the company's common stock on August 20, 2026, generating roughly $29,895 from the sale. The shares were traded at prices between $1.72 and $1.75 each, with the stock surging 136% over the past six months and 90% year-to-date, nearing a 52-week high of $1.89. Post-transaction, Kovelman still owns 105,983 shares of MYOMO, INC. common stock. Analysts suggest the stock may be overvalued relative to its Fair Value. Further insights into MYO are available through InvestingPro's ProTips and detailed analysis. Meanwhile, Myomo Inc. reported that its second-quarter results exceeded Wall Street expectations, with revenue rising by 21% year over year to $11.7 million, surpassing the projected $10.29 million. Net loss also decreased to $0.09 per share from the forecasted $0.10 per share. The company's gross margin showed significant improvement, driven by record sales of 255 MyoPro units and a bullish full-year revenue outlook, indicating a positive market trajectory for MYOMO, INC.",
  "summary": "Harry Kovelman, the Chief Medical Officer at Myomo, Inc. (NASDAQ:MYO), sold 17,250 shares of the company's common stock on August 20, 2026, resulting in a total of approximately $29,895. The transactions took place at share prices ranging from $1.72 to $1.75 each and occurred following a significant rise in the stock price, which has increased by 136% over the past six months and 90% year-to-date, nearing its 52-week high of $1.89. Despite these recent sales, Kovelman still holds 105,983 shares of MYOMO, INC. common stock. Myomo Inc. also reported its second-quarter financial results, surpassing analyst expectations with a 21% year-over-year revenue increase to $11.7 million. The company's net loss narrowed to $0.09 per share, and it raised its revenue outlook for the full year.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}